Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of Recurrence

NCT01824823 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

NETWORK

Sponsor class

Stopped Slow accrual

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: afatinib
OTHER: placebo

Sponsor

ECOG-ACRIN Cancer Research Group

Collaborators

[object Object]